Anke Kretz-Rommel
Chief Tech/Sci/R&D Officer at Bird Rock Bio, Inc.
Anke Kretz-Rommel active positions
| Companies | Position | Start | End |
|---|---|---|---|
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 2009-08-26 | - |
Career history of Anke Kretz-Rommel
Former positions of Anke Kretz-Rommel
| Companies | Position | Start | End |
|---|---|---|---|
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Corporate Officer/Principal | - | - |
Training of Anke Kretz-Rommel
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 3 |
| Germany | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
- Stock Market
- Insiders
- Anke Kretz-Rommel
- Experience
